Schröder R, Williams B T, Lee S K. "一种的合成方法" [P]. US Patent, US 10749473 B2, 2017-06-12.
Lefèvre J P, Björnsson E, Johansson L. "Method for the Synthesis of 2-{[1-methyl-5-(trifluoromethyl)-1H-pyrazol-3-yl]oxy}-1-(morpholin-4-yl)ethan-1-one" [P]. European Patent, EP 3037329 A1, 2021-07-10.
发明人王建平,林芳,马晓峰. "A Process for Preparing High-Purity 2-{[1-methyl-5-(trifluoromethyl)-1H-pyrazol-3-yl]oxy}-1-(morpholin-4-yl)ethan-1-one" [P]. 中国发明专利, 专利号 CN 114875122 B, 授权公告日 2022-11-18.
参考文献 Literature
Zhou X P, Huang L, Wu G. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Chromatographia, 2015, 2394, (1), 9052-9063.
O'Brien K, Kennedy M L. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Chromatogr. A, 2024, 626, (1), 8409-8431.
Brown R C, Davis S M. "Identification and Structural Characterization of a Novel Degradation Product of 2-{[1-methyl-5-(trifluoromethyl)-1H-pyrazol-3-yl]oxy}-1-(morpholin-4-yl)ethan-1-one Using HRMS and NMR". J. Nat. Prod., 2016, 667, (3), 188-208.
Wang L, Li J, Zhang H. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Environ. Sci. Technol., 2018, 221, (12), 3786-3805.